|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 124.80 PLN | +0.32% |
|
+1.63% | -8.37% |
| May. 27 | Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip' | RE |
| May. 15 | Scope Fluidics Q1 net loss at 13.5 million zlotys | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Diagnostics & Testing
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 108M | - | - | - | - | - |
| 3.78B | |||||
| 2.82B | - | ||||
| 1.94B | - | - | - | - | - |
| 1.82B | - | ||||
| 1.19B | - | - |
- Stock Market
- Stocks
- SCP Stock
- Charts Scope Fluidics S.A.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
